Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Precipio, Inc. (NASDAQ: PRPO).

Full DD Report for PRPO

You must become a subscriber to view this report.


Recent News from (NASDAQ: PRPO)

Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, Conn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced an agreement with PerkinElmer to ...
Source: GlobeNewswire
Date: November, 01 2018 09:15
Precipio Granted 180 Day NASDAQ Extension to Regain Compliance
Enables Company to execute on strategic and commercial initiatives with the goal of meeting the minimum $1.00 price target NEW HAVEN, Conn., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ:PRPO ), today announced notification by the N...
Source: GlobeNewswire
Date: September, 27 2018 07:37
Precipio Expands ICE-COLD PCR(TM) Lung Cancer Mutation Detection Offering
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. ( NASDAQ: PRPO ), announced today the launch of a new ICEme™ kit using its proprietary, ultra-sensi...
Source: GlobeNewswire
Date: September, 20 2018 07:37
Guardant Health on deck for IPO
Redwood City, CA-based Guardant Health ( GH ) has filed a prospectus for a $100M IPO. More news on: Guardant Health, TrovaGene, Inc., Roche Holding Ltd ADR, Healthcare stocks news, IPOs, Read more ...
Source: SeekingAlpha
Date: September, 06 2018 10:55
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2018 Results - Earnings Call Transcript
Precipio, Inc. (PRPO) Q2 2018 Results Earnings Conference Call August 23, 2018, 09:00 AM ET Executives Company Representative - Ilan Danieli - CEO Carl Iberger - CFO Analysts Presentation Operator Good morning, and welcome to Precipio's Quarterly Shareholder Update...
Source: SeekingAlpha
Date: August, 23 2018 11:26
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), wishes to remind investors and shareholders of its previously announced shareholder conference call scheduled...
Source: GlobeNewswire
Date: August, 22 2018 21:45

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-140.39620.3980.4150.39456,684

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1084,625225,94737.4535Short
2018-12-07125,829240,27952.3679Short
2018-12-0637,600161,02623.3503Cover
2018-12-0431,049378,6108.2008Cover
2018-12-0310,00049,47020.2143Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PRPO.


About Precipio, Inc. (NASDAQ: PRPO)

Logo for Precipio, Inc. (NASDAQ: PRPO)

TRANSGENOMIC is a global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD PCR, which enables use of liquid biopsies for mutation detection. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic s diagnostic technologies are designed to improve medical diagnoses and patient outcomes..

 

Contact Information

 

 

Current Management

  • Investor Relations / IR
  • Robert Patzig / Chairman, Audit Committee Member, Compensation Committee Member
  • Doit L Koppler II /
  • Michael A. Luther / Audit Committee Member, Compensation Committee Member
  • Mya Thomae / Audit Committee Member, Compensation Committee Member

Current Share Structure

  • Market Cap: $8,909,863 - 05/18/2018
  • Issue and Outstanding: 19,668,572 - 03/31/2018

 


Recent Filings from (NASDAQ: PRPO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 22 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 16 2018
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 15 2018
Withdrawal of registration statement filed under the Securities Act
Filing Type: RWFiling Source: edgar
Filing Date: August, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 15 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: June, 15 2018

 

 


Daily Technical Chart for (NASDAQ: PRPO)

Daily Technical Chart for (NASDAQ: PRPO)


Stay tuned for daily updates and more on (NASDAQ: PRPO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: PRPO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PRPO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PRPO and does not buy, sell, or trade any shares of PRPO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/